This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Aug 1;115(15):3376-8.

doi: 10.1002/cncr.24393.

Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer

PMID: 19484788
DOI: 10.1002/cncr.24393

Free article

Editorial

Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer

Judd W Moul. Cancer. 2009.

Free article

. 2009 Aug 1;115(15):3376-8.

doi: 10.1002/cncr.24393.

Author

PMID: 19484788
DOI: 10.1002/cncr.24393

No abstract available

PubMed Disclaimer

Comment on

Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival.
Akaza H, Hinotsu S, Usami M, Arai Y, Kanetake H, Naito S, Hirao Y; Study Group for the Combined Androgen Blockade Therapy of Prostate Cancer. Akaza H, et al. Cancer. 2009 Aug 1;115(15):3437-45. doi: 10.1002/cncr.24395. Cancer. 2009. PMID: 19536889 Clinical Trial.

Similar articles

Maximal androgen blockade for advanced prostate cancer.
Klotz L. Klotz L. Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):331-40. doi: 10.1016/j.beem.2008.01.004. Best Pract Res Clin Endocrinol Metab. 2008. PMID: 18471790 Review.
The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer.
Soga N, Hori Y, Ogura Y, Hayashi N, Sugimura Y. Soga N, et al. Jpn J Clin Oncol. 2012 Jun;42(6):534-40. doi: 10.1093/jjco/hys037. Epub 2012 Mar 20. Jpn J Clin Oncol. 2012. PMID: 22438406
[Hormonal treatment of cancer of the prostate: review and present status].
Ganzer R, Wieland WF, Bach T, Rössler W, Blana A. Ganzer R, et al. Dtsch Med Wochenschr. 2007 Jan 26;132(4):161-6. doi: 10.1055/s-2007-959305. Dtsch Med Wochenschr. 2007. PMID: 17230333 Review. German. No abstract available.
Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer.
Nonomura N, Takayama H, Nakayama M, Nakai Y, Kawashima A, Mukai M, Nagahara A, Aozasa K, Tsujimura A. Nonomura N, et al. BJU Int. 2011 Jun;107(12):1918-22. doi: 10.1111/j.1464-410X.2010.09804.x. Epub 2010 Nov 2. BJU Int. 2011. PMID: 21044246
Undetectable level of prostate specific antigen (PSA) nadir predicts PSA biochemical failure in local prostate cancer with delayed-combined androgen blockade.
Soga N, Arima K, Sugimura Y. Soga N, et al. Jpn J Clin Oncol. 2008 Sep;38(9):617-22. doi: 10.1093/jjco/hyn071. Epub 2008 Aug 12. Jpn J Clin Oncol. 2008. PMID: 18697759 Clinical Trial.

See all similar articles

Cited by

Primary metastatic prostate cancer between prognosis or adequate/proper medical therapy.
Mustafa M, Rass HA, Yahya M, Hamdan K, Eiss Y. Mustafa M, et al. World J Surg Oncol. 2021 Jan 4;19(1):5. doi: 10.1186/s12957-020-02111-3. World J Surg Oncol. 2021. PMID: 33397422 Free PMC article.
Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.
Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Mahmood R, Almansour M, Murshid E, Alsharm A, Alolayan A, Ahmad I, Alkushi H, Alghamdi A, Bazarbashi S. Alkhateeb S, et al. Urol Ann. 2014 Oct;6(4):278-85. doi: 10.4103/0974-7796.140959. Urol Ann. 2014. PMID: 25371601 Free PMC article.
Proven efficacy of combined androgen depletion therapy.
Akaza H. Akaza H. Curr Urol Rep. 2010 Jul;11(4):221-3. doi: 10.1007/s11934-010-0117-5. Curr Urol Rep. 2010. PMID: 20461479 No abstract available.
Hormonal therapy in metastatic prostate cancer: current perspectives and controversies.
Garg M, Singh V, Kumar M, Sankhwar SN. Garg M, et al. Oncol Rev. 2013 Sep 25;7(1):e6. doi: 10.4081/oncol.2013.e6. eCollection 2013 Apr 22. Oncol Rev. 2013. PMID: 25992227 Free PMC article. Review.
Saudi Oncology Society clinical management guidelines for prostate cancer.
Abusamra AJ, Bazarbashi S, Bahader Y, Kushi H, Rabah D, Rabbah D, Al Bogami N, Al Ghamdi K, Al Ghamdi A, Balaraj K, Seyam R, Al Otaibi M, Al Saeed E. Abusamra AJ, et al. Urol Ann. 2011 Mar;3 Suppl(Suppl):S10-6. doi: 10.4103/0974-7796.78550. Urol Ann. 2011. PMID: 21673847 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information